Header

Header

BLA

Latest News

November 22, 2022
168

Riassunto: La Biologics License Application (BLA) di Takeda per il candidato vaccino contro la dengue (TAK-003) riceve la Priority Review dalla Food and Drug Administration statunitense
Pharma / Biotech

November 1, 2022
137

A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021
Pharma / Biotech

November 1, 2022
146

A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021
Latest News

December 23, 2018
150

Aimmune Therapeutics Submits BLA to FDA for AR101 for the Treatment of Peanut Allergy in Children and Adolescents Ages 4–17